Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GLIMEPIRIDE Cause Musculoskeletal stiffness? 34 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Musculoskeletal stiffness have been filed in association with GLIMEPIRIDE (Glimepiride). This represents 0.6% of all adverse event reports for GLIMEPIRIDE.

34
Reports of Musculoskeletal stiffness with GLIMEPIRIDE
0.6%
of all GLIMEPIRIDE reports
1
Deaths
29
Hospitalizations

How Dangerous Is Musculoskeletal stiffness From GLIMEPIRIDE?

Of the 34 reports, 1 (2.9%) resulted in death, 29 (85.3%) required hospitalization, and 3 (8.8%) were considered life-threatening.

Is Musculoskeletal stiffness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GLIMEPIRIDE. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does GLIMEPIRIDE Cause?

Hypoglycaemia (1,403) Blood glucose increased (446) Acute kidney injury (339) Drug ineffective (339) Diarrhoea (257) Blood glucose decreased (232) Lactic acidosis (219) Glycosylated haemoglobin increased (214) Diabetes mellitus inadequate control (213) Hypoglycaemic coma (187)

What Other Drugs Cause Musculoskeletal stiffness?

ADALIMUMAB (10,762) METHOTREXATE (9,903) ETANERCEPT (9,744) TOFACITINIB (7,354) TOCILIZUMAB (6,346) RITUXIMAB (6,058) LEFLUNOMIDE (6,031) ABATACEPT (5,926) SECUKINUMAB (5,655) HYDROXYCHLOROQUINE (5,271)

Which GLIMEPIRIDE Alternatives Have Lower Musculoskeletal stiffness Risk?

GLIMEPIRIDE vs GLIMEPIRIDE\ROSIGLITAZONE GLIMEPIRIDE vs GLIPIZIDE GLIMEPIRIDE vs GLIVEC GLIMEPIRIDE vs GLOFITAMAB GLIMEPIRIDE vs GLOFITAMAB-GXBM

Related Pages

GLIMEPIRIDE Full Profile All Musculoskeletal stiffness Reports All Drugs Causing Musculoskeletal stiffness GLIMEPIRIDE Demographics